CLINICAL_TRIALS
research
· 2025-09-03
Clinical Trial Update: Pediatric Spinal Muscular Atrophy (SMA) China Registry
Summary
Biogen-sponsored pediatric spinal muscular atrophy registry in China is currently active and not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: ACTIVE_NOT_RECRUITING